Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Busy address KBO
26 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
AVROXA from Gent, company number BE0687774936, closed financial year 2025 with a result of € -32,501 after tax. For that financial year AVROXA recorded a gross margin of € 170,832 and equity of € 869,029. Compared with financial year 2024, the result moved from € 815,036 to € -32,501. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 16, 2026.
€ 869,029
▼ 45% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -32,501
▼ still € 815,036 profit in 2024
Profit after tax over the fiscal year.
€ 1.5 million
▲ 15% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 848,429.
People and assets in 2025
1
Average over the fiscal year, from the social balance sheet.
€ 73,672
▲ 6% vs 2024
€ 73,700 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 33,444
▲ 121% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 218,158
▼ 21% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 354,723 | € 1,009,512 | € 1,132,968 | € 170,832 | ▼ 85% |
| Profit after taxes | € -45,652 | € 576,600 | € 815,036 | € -32,501 | ▼ € 847,537 |
| Equity | € 268,777 | € 760,792 | € 1,575,829 | € 869,029 | ▼ 45% |
| Total debts | € 176,691 | € 253,713 | € 343,375 | € 927,199 | ▲ 170% |
| Cash | € 169,655 | € 671,948 | € 1,311,457 | € 1,503,972 | ▲ 15% |
| Retained profit | € 140,994 | € 717,594 | € 1,532,631 | € 848,429 | ▼ 45% |
| Dividend | € 0 | € 0 | € 0 | € 651,700 | |
| Bank debt | € 56,929 | € 31,859 | € 6,419 | € 0 | ▼ 100% |
| Balance sheet total | € 445,468 | € 1,014,506 | € 1,919,203 | € 1,796,228 | ▼ 6% |
| Employees (FTE) | - | - | 1 | 1 |
Key figures of AVROXA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to AVROXA?
What happened at AVROXA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 32,501 (▼ € 847,537 vs 2024). Source: NBB ↗
- New establishment in Gent. KBO
- Start of the company according to the CBE. KBO
- Richard Hoogenboom became a director. NBB
- Victor Retamero De La Rosa became a director. NBB
In short
From € 45,652 loss in 2022 to € 32,501 loss in 2025.
Paid € 253,980 in corporate taxes since 2022.
Best year ever: 2024, with € 815,036 profit.
On average € 170,800 of value added per employee in 2025.
A new publication or filing at AVROXA? We notify you, reason included.
Follow AVROXADatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind AVROXA are Richard Hoogenboom and Victor Retamero De La Rosa.
Directors
According to the 2025 annual accounts
Richard Hoogenboom
Director
since 2018
Victor Retamero De La Rosa
Director
since 2018
Establishments
Establishment units
Physical locations of this company
Technologiepark-Zwijnaarde 82
9052 Gent
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 26 companies are registered at this address.
All companies at this address →CONTREL EUROPE
€ 250,724 gross margin · 2025
INCUBATIE- EN INNOVATIECENTRUM UNIVERSITEIT
€ 1.4 million gross margin · 2025
VP VENTURES
€ -1,670 gross margin · 2025
SENSNET
Inbiose
€ 6.3 million revenue · 2025
+21 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Certifications & Partners
Hosting & Email
Email provider
Microsoft 365
Hosting
CLOUDFLARENET - Cloudflare, Inc., US
DNS
Cloudflare DNS
Domain
Domain
ultroxa.com
Registered
2015-05-01
Registrar
GoDaddy.com, LLC
Expires
2026-05-01
Website info
Features
Security
Network
Details
- Company number
- 0687.774.936
- VAT number
- BE 0687.774.936
- Registered office
- Technologiepark-Zwijnaarde 82, 9052 Gent
- Names & denominations
- AVROXA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 10 January 2018
- Peppol
- Active · Active since 8 Jan 2026
- Contact
- ultroxa.com
- Activities · NACE
Vervaardiging van kunststoffen in primaire vormen
Vervaardiging van andere organische chemische basisproducten
Vervaardiging van andere producten van kunststof
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Vervaardiging van verf, vernis ed, drukinkt en mastiek
Vervaardiging van andere chemische producten, neg
Vervaardiging van synthetische en kunstmatige vezels
Vervaardiging van overige farmaceutische producten
+6